- Home
- SNX vs NBIX Comparison
SNX vs NBIX Comparison
Compare SNX & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNX | NBIX |
|---|---|---|
| Founded | 1980 | 1992 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 15.2B |
| IPO Year | 2003 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SNX | NBIX |
|---|---|---|
| Price | $151.02 | $148.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 20 |
| Target Price | $169.00 | ★ $175.10 |
| AVG Volume (30 Days) | 604.7K | ★ 938.9K |
| Earning Date | 01-08-2026 | 10-28-2025 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 18.98 | 12.44 |
| EPS | ★ 9.21 | 4.19 |
| Revenue | ★ $60,973,509,000.00 | $2,682,700,000.00 |
| Revenue This Year | $7.25 | $23.76 |
| Revenue Next Year | $4.50 | $18.01 |
| P/E Ratio | ★ $16.91 | $36.45 |
| Revenue Growth | 6.94 | ★ 19.61 |
| 52 Week Low | $92.23 | $84.23 |
| 52 Week High | $167.76 | $160.18 |
Technical Indicators
Market Signals| Indicator | SNX | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 48.34 |
| Support Level | $148.97 | $151.09 |
| Resistance Level | $158.68 | $155.55 |
| Average True Range (ATR) | 3.12 | 4.41 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 21.11 | 19.32 |
Price Performance
Historical ComparisonAbout SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.